ANGIOTECH PHARMACEUTICALS INC Net Cash Provided by (Used in) Continuing Operations
ANGIOTECH PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Continuing Operations of $23.77 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-12-31 was -$13.77M.
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-09-30 was $1.72M.
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-06-30 was $22.92M.
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-03-31 was $12.90M.
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2012 was $23.77M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 2 month | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 5 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 8 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | -$13.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$12.05M derived: sum of 2 quarters · filed 2013-03-28 | $10.87M derived: sum of 3 quarters · filed 2013-03-28 | $23.77M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $1.72M 10-Q · filed 2012-11-14 | $24.64M derived: sum of 2 quarters · filed 2012-11-14 | $37.54M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $22.92M 10-Q/A · filed 2012-09-13 | $35.82M 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $12.90M 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | -$8.05M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | -$2.39M 10-Q · filed 2012-11-14 | -$10.97M 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | -$8.59M 10-Q/A · filed 2012-09-13 |